Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess the Market Potential of a Carbon Dioxide Nasal Spray in Congested Subjects

NCT02113449 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02113449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02113449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess the Market Potential of a Carbon Dioxide Nasal Spray in Congested Subjects
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2013
Completion date
February 28, 2014
Enrollment
147 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

nasal congestion